Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
McKinsey
Citi
Colorcon
Teva
Merck
Medtronic
McKesson

Generated: December 15, 2018

DrugPatentWatch Database Preview

SYNAREL Drug Profile

« Back to Dashboard

Which patents cover Synarel, and what generic alternatives are available?

Synarel is a drug marketed by Gd Searle Llc and is included in one NDA.

The generic ingredient in SYNAREL is nafarelin acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nafarelin acetate profile page.

Drug patent expirations by year for SYNAREL
Medical Subject Heading (MeSH) Categories for SYNAREL
Synonyms for SYNAREL
(6-D-(2-Naphthyl)alanine)LHRH acetate
(6-D-(2-Naphthyl)alanine)luteinizing hormone-releasing hormone acetate
(D-2-Nal6)-LHRH
(S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-15-(naphthalen-2-ylmethyl)-1,4,7,10,13,16,19-heptaoxo-1-((S)-5
121897-31-2
144949-01-9
1X0094V6JV
6-(3-(2-Naphthalenyl)-D-alanine)luteinizing hormone-releasing factor (pig)
76932-56-4
76932-56-4 (Parent)
76932-60-0
76932-60-0 (monoacetate (salt))
78115-72-7
86220-42-0 (acetate (salt), hydrate)
932N564
ABP000520
AKOS015895038
AKOS030529554
AM006837
BDBM84707
BIDD:GT0760
C66H83N17O13
CN-156
CS-5747
D08WYM
DB00666
DTXSID50227720
HS-2018
HY-P0057
K335
LHRH, Ala(2-naphthyl)(6)-
LS-88242
Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-
Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-, monoacetate (salt)
Luteinizing hormone-releasing factor (swine), 6-(3-(2-naphthalenyl)-D-alanine)-, monoacetate (salt)
Luteinizing hormone-releasing hormone, (6-D-(2-naphthyl)alanine)-, acetate
MolPort-006-823-890
NAFARELIN
Nafarelin (INN)
Nafarelin [INN:BAN]
NAFARELIN ACETATE
Nafarelin acetate anhydrous
Nafarelin Acetate, Hydrate
Nafarelin Acetate(Synarel)/
Nafarelina
Nafarelina [Spanish]
Nafareline
Nafareline [French]
Nafarelinum
Nafarelinum [Latin]
RS-94991-298
SC-17368
SCHEMBL166006
SCHEMBL22518
Synarel (TN)
Synarela
TH2HMT9YBQ
UNII-1X0094V6JV
UNII-TH2HMT9YBQ

US Patents and Regulatory Information for SYNAREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc SYNAREL nafarelin acetate SPRAY, METERED;NASAL 019886-001 Feb 13, 1990 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
McKinsey
Citi
Colorcon
Teva
Merck
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.